Colloid solutions: A clinical update

Journal of Anesthesia

Volumn 24, Issue 6, 2010, Pages 913-925

  Niemi, Tomi T ^a   Miyashita, Ryo ^b   Yamakage, Michiaki ^b  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b SAPPORO MEDICAL UNIVERSITY HOSPITAL   (Japan)

Author keywords

Degree of substitution; Hydroxyethyl starch (HES); Intravascular volume; Molecular size

Indexed keywords

ALBUMIN; DEXTRAN; GELATIN; HETASTARCH; PLASMA SUBSTITUTE;

ANAPHYLAXIS; BLOOD CLOTTING; BLOOD VOLUME; DRUG HYPERSENSITIVITY; DRUG SAFETY; FLUID RESUSCITATION; FLUID THERAPY; GLOMERULUS FILTRATION; HEMODYNAMICS; HUMAN; HYPOVOLEMIA; KIDNEY FUNCTION; MOLECULAR SIZE; MOLECULAR WEIGHT; OSMOTIC PRESSURE; OUTCOME ASSESSMENT; RENAL REPLACEMENT THERAPY; REVIEW; TUBE FLOW;

ALBUMINS; BLOOD COAGULATION; COLLOIDS; DEXTRANS; GELATIN; HETASTARCH; HUMANS; HYPOVOLEMIA; INFUSIONS, INTRAVENOUS; KIDNEY FUNCTION TESTS; MOLECULAR WEIGHT; PLASMA SUBSTITUTES; SOLUTIONS; SOLVENTS;

EID: 78651472336     PISSN: 09138668     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00540-010-1034-y     Document Type: Review

References (126)

1. Bunn F, Trivedi D, Ashraf S. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev. 2008. doi: 10.1002/14651858.CD001319.pub.2.
2. A Perner A Åneman AB Guttormsen S Kárason J Tenhunen 2008 Preferences for colloid use in Scandinavian intensive care units Acta Anaesthesiol Scand 52 750 758
3. D Chappell M Jacob K Hofmann-Kiefer P Conzen M Rehm 2008 A rational approach to perioperative fluid management Anesthesiology 109 723 740 18813052
4. MP Grocott MG Mythen TJ Gan 2005 Perioperative fluid management and clinical outcomes in adults Anesth Analg 100 1093 1106 15781528
5. Perel P, Roberts I, Pearson M. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2007. doi: 10.1002/14651858.CD000567.pub3.
6. S Hiippala K Linko G Myllylä M Lalla R Hekali A Makelainen 1995 Replacement of major surgical blood loss by hypo-oncotic or conventional plasma substitutes Acta Anaesthesiol Scand 39 228 235 1:STN:280:DyaK2MzhtlCrsg%3D%3D 7540789
7. KP Moore F Wong P Gines M Bernardi A Ochs F Salerno P Angeli M Porayko R Moreau G Garcia-Tsao W Jimenez R Planas V Arroyo 2003 The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club Hepatology 38 258 266 12830009
8. ME Barron M Wilkes RJ Navickis 2004 A systematic review of the comparative safety of colloids Arch Surg 139 552 563 1:CAS:528: DC%2BD2cXks1Kitr4%3D 15136357
9. MC Laxenaire C Charpentier L Feldman 1994 Anaphylactoid reactions to colloid plasma substitutes: incidence risk factors mechanisms. A French multicenter prospective study Ann Fr Anest Reanim 13 301 310 1:STN:280:DyaK2M%2FosFWjtA%3D%3D
10. H Kohler H Zschiedrich R Clasen A Linfante H Gamm 1982 The effects of 500 ml 10% hydroxyethyl starch 200/0.5 and 10% dextran 40 on blood volume, colloid osmotic pressure, and renal function in human volunteers Anaesthetist 31 61 67 1:STN:280:DyaL383gsVantw%3D%3D
11. KG Ljungström 1993 Safety of dextran in relation to other colloids-ten years experience with hapten inhibition Infus Ther Transfus Med 20 206 210
12. P Van der Linden BE Ickx 2006 The effects of colloid solutions on hemostasis Can J Anaesth 53 S30 S39 16766789
13. HS Nearman ML Herman 1991 Toxic effects of colloids in the intensive care unit Crit Care Clin 7 713 723 1:STN:280:DyaK3Mzit1OjtA%3D%3D 1713807
14. GC Kramer CE Wade DS Prough 1998 Hypertonic saline dextran: efficacy and regulatory approval Acta Anaesthesiol Scand 42 141 144 1:STN:280: DyaK1c7mvF2gsw%3D%3D 9509193
15. S Peano G Reiner M Carbonatto L Bodenbender P Boland KJ Abel 2000 Determination of the clearance factor for transmissible spongiform encephalopathy agents during the manufacturing process of polygeline Intensive Care Med 26 608 612 1:STN:280:DC%2BD3M%2Fjt1eqtA%3D%3D 10923737
16. J Treib JF Baron MT Grauer RG Strauss 1999 An international view of hydroxyethyl starches Intensive Care Med 25 258 268 1:STN:280: DyaK1M3ksVWltw%3D%3D 10229159
17. C Jungheinrich TA Neff 2005 Pharmacokinetics of hydroxyethyl starch Clin Pharmacokinet 44 681 699 1:CAS:528:DC%2BD2MXntlWjurg%3D 15966753
18. M Westphal MFM James S Kozek-Langenecker R Stocker B Guidet H van Aken 2009 Hydroxyethyl starches Anesthesiology 111 187 202 1:CAS:528: DC%2BD1MXnsFyjtr0%3D 19512862
19. GB Lehmann F Asskali M Boll MA Burmeister G Marx R Hilgers H Förster 2007 HES 130/0.42 shows less alteration of pharmacokinetics than HES 200/0.5 when dosed repeatedly Br J Anaesth 98 635 644 1:CAS:528:DC%2BD2sXmslKktb4%3D 17456491
20. CH Shatney IH Chaudry 1994 Hydroxyethyl starch administration does not depress reticuloendothelial function or increase mortality from sepsis Circ Shock 13 21 26
21. C Sharland A Huggett MS Nielson PS Friedmann 1999 Persistent pruritus after pentastarch infusions in intensive care patients Anaesthesia 54 500 501 1:STN:280:DC%2BD3cvksVOrug%3D%3D 10995162
22. PW Morgan JC Berridge 2000 Giving long-persistent starch as volume replacement can cause pruritus after cardiac surgery Br J Anaesth 85 696 699 1:STN:280:DC%2BD3M%2Fjs1SqtA%3D%3D 11094582
23. P Christensen J Andersson SE Rasmussen PK Andersen SW Henneberg 2001 Changes in circulating blood volume after infusion of hydroxyethyl starch 6% in critically ill patients Acta Anaesthesiol Scand 45 414 420 1:CAS:528: DC%2BD3MXivVOgu78%3D 11300378
24. M Rehm M Haller V Orth U Kreimeier M Jacob H Dressel S Mayer H Brechtelsbauer U Finsterer 2001 Changes in blood volume and hematocrit during acute preoperative volume loading with 5% albumin or 6% hetastarch solutions in patients before radical hysterectomy Anesthesiology 95 849 856 1:STN:280:DC%2BD3MrmtVSktg%3D%3D 11605923
25. ®) during acute preoperative normovolemic hemodilution Anaesthesist 52 896 904 1:STN:280:DC%2BD3srjs1Cktg%3D%3D 14618245
26. M Rehm V Orth U Kreimeier M Thiel M Haller H Brechtelsbauer U Finsterer 2000 Changes in intravascular volume during acute normovolemic hemodilution and intraoperative retransfusion in patients with radical hysterectomy Anesthesiology 92 657 664 1:STN:280:DC%2BD3c7ot1ylsA%3D%3D 10719943
27. JA Carcillo AL Davis A Zaritsky 1991 Role of early fluid resuscitation in pediatric septic shock JAMA 266 1242 1245 1:STN:280:DyaK3MzjtlWjtg%3D%3D 1870250
28. R Venn A Steele P Richardson J Poloniecki M Grounds P Newman 2002 Randomized controlled trial to investigate influence of the fluid challenge on duration of hospital stay and perioperative morbidity in patients with hip fractures Br J Anaesth 88 65 71 1:STN:280:DC%2BD387kslaisQ%3D%3D 11881887
29. M Varpula S Karlsson I Parviainen E Ruokonen V Pettilä Finnsepsis Study Group 2007 Community-acquired septic shock: early management and outcome in a nationwide study in Finland Acta Anaesthesiol Scand 51 1320 1326 1:CAS:528:DC%2BD2sXhtlyrsbnP 17944634
30. E Rivers B Nguyen S Havstad J Ressler A Muzzin B Knoblich E Peterson M Tomlanovich 2001 Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 345 1368 1377 1:STN:280:DC%2BD38%2FmsFGjtA%3D%3D 11794169
31. JA Kellum 2002 Fluid resuscitation and hyperchloremic acidosis in experimental sepsis: improved short-term survival and acid-base balance with Hextend compared with saline Crit Care Med 30 300 305 11889298
32. Z Friedman H Berkenstadt S Preisman A Perel 2003 A comparison of lactated Ringer's solution to hydroxyethyl starch 6% in a model of severe hemorrhagic shock and continuous bleeding in dogs Anesth Analg 96 39 45 1:CAS:528: DC%2BD3sXht1yjtb0%3D 12505920
33. C Boura A Caron D Longrois PM Mertes P Labrude P Menu 2003 Volume expansion with modified hemoglobin solution, colloids, or crystalloid after hemorrhagic shock in rabbits: effects in skeletal muscle oxygen pressure and use versus arterial blood velocity and resistance Shock 19 176 182 12578128
34. GS Moss RJ Lowe J Jilek HD Levine 1981 Colloid or crystalloid in the resuscitation of hemorrhagic shock: a controlled clinical trial Surgery (St. Louis) 89 434 438 1:STN:280:DyaL3M7ltlKjtg%3D%3D
35. KK Nagy J Davis J Duda J Fildes R Roberts J Barrett 1993 A comparison of pentastarch and lactated Ringer's solution in the resuscitation of patients with hemorrhagic shock Circ Shock 40 289 294 1:STN:280:DyaK3szos1yntA%3D%3D 7690689
36. RN Younes KC Yin CJ Amino M Itinoshe M Rocha e Silva D Birolini 1998 Use of pentastarch solution in the treatment of patients with hemorrhagic hypovolemia: randomized phase II study in the emergency room World J Surg 22 2 5 1:STN:280:DyaK1c7is12jsw%3D%3D 9465753
37. RJ Lowe GS Moss J Jilek HD Levine 1977 Crystalloid vs colloid in the etiology of pulmonary failure after trauma: a randomized trial in man Surgery (St. Louis) 81 676 683 1:STN:280:DyaE2s7nsFWlug%3D%3D
38. J Modig 1983 Advantages of dextran 70 over Ringer acetate solution in shock treatment and in prevention of adult respiratory distress syndrome: a randomized study in man after traumatic-haemorrhagic shock Resuscitation 10 219 226 1:STN:280:DyaL2c%2Fnt1ajtA%3D%3D 6196822
39. J-L Vincent 2007 The pros and cons of hydroxyethyl starch solutions Anesth Analg 104 484 486 17312191
40. J Boldt 2000 Volume replacement in the surgical patient-does the type of solution make a difference? Br J Anaesth 84 783 793 1:CAS:528: DC%2BD3cXksF2kt7g%3D 10895757
41. S Tølløfsrud JL Svennevig H Breivik U Kongsgaard M Ezer E Hysing B Mohr E Seem O Geiran M Abdelnour T Frøysaker H Noddeland 1995 Fluid balance and pulmonary functions during and after coronary artery surgery: Ringer's acetate compared with dextran, polygeline, or albumin Acta Anaesthesiol Scand 39 671 677 7572019
42. G Friedman S Jankowski M Shahla J Gomez JL Vincent 2008 Hemodynamic effects of 6 and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients J Clin Anesth 20 528 533 1:CAS:528:DC%2BD1cXhsVCnu7nI 19019650
43. WH Bickell MJ Wall Jr PE Pepe RR Martin VF Ginger MK Allen KL Mattox 1994 Immediate versus delayed fluid resuscitation for hypotensive patients with penetrating torso injuries N Engl J Med 331 1105 1109 1:STN:280: DyaK2M%2FitFGgsQ%3D%3D 7935634
44. MG Mythen AR Webb 1995 Preoperative plasma volume expansion reduces the incidence of gut mucosal hypoperfusion during cardiac surgery Arch Surg 130 423 429 1:STN:280:DyaK2M3isFOgtg%3D%3D 7535996
45. MM Krausz Y Bashenko M Hirsh 2001 Crystalloid and colloid resuscitation of uncontrolled hemorrhagic shock following massive splenic injury Shock 16 383 388 1:STN:280:DC%2BD3MnkslCktw%3D%3D 11699078
46. MS Karanko 1987 Effects of three colloid solutions on plasma volume and hemodynamics after coronary bypass surgery Crit Care Med 15 1015 1022 1:STN:280:DyaL1c%2FlsVSmsw%3D%3D 2445528
47. RC Gallandat Huet AW Siemons D Baus WT van Rooyen-Butijn JA Haagenaars W van Oeveren F Bepperling 2000 A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery Can J Anaesth 47 1207 1215 1:STN:280:DC%2BD3M7ivFSlsQ%3D%3D 11132743
48. G Haisch J Boldt C Krebs S Suttner A Lehmann F Isgro 2001 Influence of a new hydroxyethyl starch preparation (HES 130/0.4) on coagulation in cardiac surgical patients J Cardiothorac Vasc Anesth 15 316 321 1:STN:280: DC%2BD3MzmsVKktA%3D%3D 11426361
49. G Haisch J Boldt C Krebs B Kumle S Suttner A Schulz 2001 The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery Anesth Analg 92 565 571 1:CAS:528:DC%2BD3MXitF2gs7s%3D 11226079
50. P Van der Linden S De Hert A Daper A Trenchant D Schmartz P Defrance P Kimbimbi 2004 3.5% Urea-linked gelatin is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients Can J Anaesth 51 236 241 15010405
51. P Van der Linden S De Hert D Deraedt D Deraedt S Cronheecke K De Decker R De Paep I Rodrigus A Daper A Trenchant 2005 Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for volume expansion in cardiac surgery patients: the effects on perioperative bleeding and transfusion needs Anesth Analg 101 629 634 16115963
52. YJ Mortelmans G Vermaut AM Verbruggen JF Arnout J Vermylen H Van Aken LA Mortelmans 1995 Effects of 6% hydroxyethyl starch and 3% modified fluid gelatin on intravascular volume and coagulation during intraoperative hemodilution Anesth Analg 81 1235 1242 1:CAS:528:DyaK28XmvVyitA%3D%3D 7486110
53. F Schortgen JC Lacherade F Bruneel I Cattaneo F Hemery F Lemaire L Brochard 2001 Effects of hydroxyethyl starch and gelatin on renal function in severe sepsis: a multicentre randomised study Lancet 357 911 916 1:CAS:528:DC%2BD3MXit1Wgur8%3D 11289347
54. Z Molnar A Mikor T Leiner T Szakmany 2004 Fluid resuscitation with colloids of different molecular weight in septic shock Intensive Care Med 30 1356 1360 15127186
55. J Boldt M Heesen M Müller M Papsdorf G Hempelmann 1996 The effects of albumin versus hydroxyethyl starch solution on cardiorespiratory and circulatory variables in critically ill patients Anesth Analg 83 254 261 1:CAS:528:DyaK28Xlt1Siu7w%3D 8694302
56. J Boldt M Müller D Mentges M Papsdorf G Hempelmann 1998 Volume therapy in the critically ill: is there a difference? Intensive Care Med 24 28 36 1:STN:280:DyaK1c7mtl2nuw%3D%3D 9503219
57. D Palumbo G Servillo L D'Amato ML Volpe G Capogrosso E De Robertis O Piazza R Tufano 2006 The effects of hydroxyethyl starch solution in critically ill patients Minerva Anestesiol. 72 655 664 1:STN:280:DC%2BD28vktFKisw%3D%3D 16865084
58. A Kuitunen R Suojaranta-Ylinen S Kukkonen T Niemi 2007 A comparison of the haemodynamic effects of 4% succinylated gelatin, 6% hydroxyethyl starch (200/0.5), and 4% human albumin after cardiac surgery Scand J Surg 96 72 78 1:STN:280:DC%2BD2s3lt1Kiuw%3D%3D 17461317
59. T Niemi A Schramko A Kuitunen S Kukkonen R Suojaranta-Ylinen 2008 Haemodynamics and acid-base equilibrium after cardiac surgery: comparison of rapidly degradable hydroxyethyl starch solutions and albumin Scand J Surg 97 259 265 1:STN:280:DC%2BD1cnitlCjsA%3D%3D 18812277
60. EW Moretti KM Robertson H El-Moalem TJ Gan 2003 Intraoperative colloid administration reduces postoperative nausea and vomiting and improves postoperative outcomes compared with crystalloid administration Anesth Analg 96 611 617 12538221
61. MT Haupt EC Rackow 1982 Colloid osmotic pressure and fluid resuscitation with hetastarch, albumin, and saline solutions Crit Care Med 10 159 162 1:STN:280:DyaL387jsl2msg%3D%3D 6174274
62. T Prien N Backhaus F Pelster W Pircher H Bunte P Lawin 1990 Effect of intraoperative fluid administration and colloid osmotic pressure on the formation of intestinal edema during gastrointestinal surgery J Clin Anesth 2 317 323 1:STN:280:DyaK3M7gsVSgtQ%3D%3D 1702977
63. SB Rizoli 2003 Crystalloids and colloids in trauma resuscitation: a brief overview of the current debate J Trauma 54 S82 S88 12768108
64. JA Lowell C Schifferdecker DF Driscoll PN Benotti BR Bistrian 1990 Postoperative fluid overload: not a benign problem Crit Care Med 18 728 733 1:STN:280:DyaK3czgsFCqsQ%3D%3D 2364713
65. ER Schertel DA Allen WW Muir BD Hansen 1996 Evaluation of a hypertonic sodium chloride/dextran solution for treatment of traumatic shock in dogs J Am Vet Med Assoc. 208 366 370 1:CAS:528:DyaK28XhsVSjsL4%3D 8575966
66. G Marx MM Cobas T Schuerholz B Vangerow KF Gratz H Hecker R Sumpelmann H Rueckoldt M Leuwer 2002 Hydroxyethyl starch and modified fluid gelatin maintain plasma volume in a porcine model of septic shock with capillary leakage Intensive Care Med 28 629 635 1:STN:280:DC%2BD383ovVCqsg%3D%3D 12029413
67. H Zhang S Voglis CH Kim AS Slutsky 2003 Effects of albumin and Ringer's lactate on production of lung cytokines and hydrogen peroxide after resuscitated hemorrhage and endotoxemia in rats Crit Care Med 31 1515 1522 1:CAS:528:DC%2BD3sXlvFansbc%3D 12771627
68. MD Menger FU Sack F Hammersen K Messmer 1989 Tissue oxygenation after prolonged ischemia in skeletal muscle: therapeutic effect of prophylactic isovolemic hemodilution Adv Exp Med Biol 248 387 395 1:STN:280: DyaL1MzptVSqtw%3D%3D 2782161
69. AR Webb RF Moss D Tighe MG Mythen N al-Saady AE Joseph ED Bennett 1992 A narrow range, medium molecular weight pentastarch reduces structural organ damage in a hyperdynamic porcine model of sepsis Intensive Care Med 18 348 355 1:STN:280:DyaK3s7gslCnsg%3D%3D 1281848
70. X Feng W Yan Z Wang J Liu M Yu S Zhu J Xu 2007 Hydroxyethyl starch, but not modified fluid gelatin, affects inflammatory response in a rat model of polymicrobial sepsis with capillary leakage Anesth Analg 104 624 630 1:CAS:528:DC%2BD2sXhvFWrtrk%3D 17312221
71. J Boldt B Zickmann J Rapin H Hammermann F Dapper G Hempelmann 1994 Influence of volume replacement with different HES-solutions on microcirculatory blood flow in cardiac surgery Acta Anaesthesiol Scand 38 432 438 1:STN:280:DyaK2M%2FivVertg%3D%3D 7524255
72. TA Neff L Fischler M Mark R Stocker WH Reinhart 2005 The influence of two different hydroxyethyl starch solutions (6% HES 130/0.4 and 200/0.5) on blood viscosity Anesth Analg 100 1773 1780 1:CAS:528:DC%2BD2MXktlKrs7c%3D 15920212
73. K Lang J Boldt S Suttner G Haisch 2001 Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery Anesth Analg 93 405 409 1:STN:280:DC%2BD3MvislSksQ%3D%3D 11473870
74. K Lang S Suttner J Boldt B Kumle D Nagel 2003 Volume replacement with HES 130/0.4 may reduce the inflammatory response in patients undergoing major abdominal surgery Can J Anaesth 50 1009 1016 14656778
75. G Martin E Bennett-Guerrero H Wakeling B Kumle D Nagel 2002 A prospective, randomized comparison of thromboelastographic coagulation profile in patients receiving lactated Ringer's solution, 6% hetastarch in a balanced-saline vehicle, or 6% hetastarch in saline during major surgery J Cardiothorac Vasc Anesth 16 441 446 1:STN:280:DC%2BD38vgsVGhtg%3D%3D 12154422
76. J Boldt T Schöllhorn J Münchbach M Pabsdorf 2007 A total balanced volume replacement strategy using a new balanced hydroxyethyl starch preparation (6% HES 130/0.42) in patients undergoing major abdominal surgery Eur J Anaesthesiol 24 267 275 1:CAS:528:DC%2BD2sXkt1Wlt7Y%3D 17054812
77. J Boldt S Suttner C Brosch A Lehmann K Röhm A Mengistu 2009 The influence of a balanced volume replacement concept on inflammation, endothelial activation, and kidney integrity in elderly cardiac surgery patients Intensive Care Med 35 462 470 18807007
78. G Schierhout I Roberts 1999 Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials BMJ 316 961 964
79. PTL Choi G Yip LG Quinonez DJ Cook 1999 Crystalloids vs. colloids in fluid resuscitation: a systematic review Crit Care Med 27 200 210 1:STN:280:DyaK1M7jtFKitA%3D%3D 9934917
80. Roberts I, Alderson P, Bunn F, Chinnock P, Ker K, Schierhout G. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2004. doi: 10.1002/14651858.CD000567.pub3.
81. MA Stockwell A Scott A Day B Riley N Soni 1992 Colloid solutions in the critically ill. A randomised comparison of albumin and polygeline 2. Serum albumin concentration and incidences of pulmonary oedema and acute renal failure Anaesthesia 47 7 9 1:STN:280:DyaK387mtFamtg%3D%3D 1536412
82. J Boldt C Brosch M Ducke M Papsdorf A Lehmann 2007 Influence of volume therapy with a modern hydroxyethyl starch preparation on kidney function in cardiac surgery patients with compromised renal function: a comparison with human albumin Crit Care Med 35 2740 2746 1:CAS:528:DC%2BD2sXhsVGhsrvM 17893629
83. JL Vincent MJ Dubois RJ Navickis MM Wilkes 2003 Hypoalbuminemia in acute illness: is there a rationale for intervention? A meta-analysis of cohort studies and controlled trials Ann Surg 237 319 334 12616115
84. J Boldt C Brosch K Röhm A Lehmann A Mengistu S Suttner 2008 Is albumin administration in hypoalbuminemic elderly cardiac surgery patients of benefit with regard to inflammation, endothelial activation, and long-term kidney function? Anesth Analg 107 1496 1503 1:CAS:528:DC%2BD1cXht1KnsrzN 18931204
85. C Holm 2000 Resuscitation in shock associated with burns. Tradition or evidence-based medicine? Resuscitation 44 157 164 1:STN:280: DC%2BD3c3os1Kjsg%3D%3D 10825614
86. J Boldt M Papsdorf 2008 Fluid management in burn patients: results from a European survey: more questions than answers Burns 34 328 338 18201828
87. Cochrane Injuries Group Albumin Reviewers 1998 Human albumin administration in critically ill patients: systematic review of randomised controlled trials BMJ 317 235 240
88. S Finfer R Bellomo N Boyce J French J Myburgh R Norton 2004 A comparison of albumin and saline for fluid resuscitation in the intensive care unit N Engl J Med 350 2247 2256 1:CAS:528:DC%2BD2cXksVehs70%3D 15163774
89. MM Wilkes RJ Navickis 2001 Patient survival after human albumin administration: a meta-analysis of randomized, controlled trials Ann Intern Med 135 149 164 1:CAS:528:DC%2BD3MXmtlWktr8%3D 11487482
90. Alderson P, Bunn F, Lefebvre C, Li Wan Po A, Li L, Roberts I, Schierhout G, Albumin Reviewers. Human albumin solution for resuscitation and volume expansion in critically ill patients. Cochrane Database Syst Rev. 2004. doi: 10.1002/14651858.CD001208.pub2.
91. MT Coughlin DC Angus 2003 Economic evaluation of new therapies in critical illness Crit Care Med 31 S7 S16 12544971
92. P Sort M Navasa V Arroyo X Aldeguer R Planas L Ruiz-del-Arbol L Castells V Vargas G Soriano M Guevara P Gines J Rodes 1999 Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis N Engl J Med 341 403 409 1:CAS:528:DyaK1MXltlyltb8%3D 10432325
93. FM Brunkhorst C Engel F Bloos A Meier-Hellmann M Ragaller N Weiler O Moerer M Gruendling M Oppert S Grond D Olthoff U Jaschinski S John R Rossaint T Welte M Schaefer P Kern E Kuhnt M Kiehntopf C Hartog C Natanson M Loeffler K Reinhart German Competence Network Sepsis (SepNet) 2008 Intensive insulin therapy and pentastarch resuscitation in severe sepsis N Engl J Med 358 125 139 1:CAS:528:DC%2BD1cXltFWltQ%3D%3D 18184958
94. JD Rozich RV Paul 1989 Acute renal failure precipitated by elevated colloid osmotic pressure Am J Med 87 359 360 1:STN:280:DyaL1MzntFyisQ%3D%3D 2773975
95. CS Wilcox 1983 Regulation of renal blood flow by plasma chloride J Clin Invest 71 726 735 1:CAS:528:DyaL3sXhsVWhurs%3D 6826732
96. C Legendre E Thervet B Page A Percheron LH Noël H Kreis 1993 Hydroxyethyl starch and osmotic-nephrosis-like lesions in kidney transplantation Lancet 342 248 249 1:STN:280:DyaK3szhs1OlsA%3D%3D 7686994
97. ML Cittanova I Leblanc CH Legendre C Mouquet B Riou P Coriat 1996 Effect of hydroxyethyl starch in brain-dead kidney donors on renal function in kidney-transplant recipients Lancet 348 1620 1622 1:CAS:528:DyaK2sXjtVamuw%3D%3D 8961992
98. A Deman P Peeters J Sennesael 1999 Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: a retrospective, multicentre analysis Nephrol Dial Transplant 14 1517 1520 1:CAS:528: DyaK1MXjvFGqtL4%3D 10383017
99. V Blasco M Leone F Antonini A Geissler J Albanèse C Martin 2008 Comparison of the novel hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.6 in brain-dead donor resuscitation on renal function after transplantation Br J Anaesth 100 504 508 1:CAS:528:DC%2BD1cXjsVCrurY%3D 18256055
100. Y Sakr D Payen K Reinhart FS Sipmann E Zavala J Bewley G Marx JL Vincent 2007 Effects of hydroxyethyl starch administration on renal function in critically ill patients Br J Anaesth 98 216 224 1:CAS:528:DC%2BD2sXivF2lu70%3D 17251213
101. B Kumle J Boldt S Piper C Schmidt S Suttner S Salopek 1999 The influence of different intravascular volume replacement regimens on renal function in the elderly Anesth Analg 89 1124 1130 1:STN:280:DC%2BD3c%2FhvFamsg%3D%3D 10553822
102. J Boldt T Brenner A Lehmann J Lang B Kumle C Werling 2003 Influence of two different volume replacement regimens on renal function in elderly patients undergoing cardiac surgery: comparison of new starch preparation with gelatin Intensive Care Med 29 763 769 12665995
103. J Boldt C Brosch K Röhm M Papsdorf A Mengistu 2008 Comparison of the effects of gelatin and a modern hydroxyethyl starch solution on renal function and inflammatory response in elderly cardiac surgery patients Br J Anaesth 100 457 464 1:CAS:528:DC%2BD1cXjsVCrurg%3D 18305082
104. A Mahmood P Gosling RK Vohra 2007 Randomized clinical trial comparing the effects on renal function of hydroxyethyl starch or gelatin during aortic aneurysm surgery Br J Surg 94 427 433 1:CAS:528:DC%2BD2sXlsVWjtbg%3D 17380548
105. ®) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial Eur J Anaesthesiol 25 986 994 1:CAS:528:DC%2BD1MXjvV2lsg%3D%3D 18492315
106. C Jungheinrich R Scharpf M Wargenau F Bepperling JF Baron 2002 The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 (6%, 500 mL) in mild-to-severe renal impairment Anesth Analg 95 544 551 1:CAS:528:DC%2BD38Xntl2qsr8%3D 12198032
107. M Dehne J Muhling A Sablotzki K Dehne N Sucke G Hempelmann 2001 Hydroxyethyl starch (HES) does not directly affect renal function in patients with no prior renal impairment J Clin Anesth 13 103 111 1:CAS:528: DC%2BD3MXivFegsLs%3D 11331169
108. TA Neff M Doelberg C Jungheinrich A Sauerland DR Spahn R Stocker 2003 Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury Anesth Analg 96 1453 1459 1:CAS:528: DC%2BD3sXktVSqtLY%3D 12707149
109. J Treib A Haass G Pindur 1997 Coagulation disorders caused by hydroxyethyl starch Thromb Haemost 78 974 983 1:CAS:528:DyaK2sXmtVejsro%3D 9308738
110. AP Jonville-Bera E Autret-Leca Y Gruel 2001 Acquired type I von Willebrand's disease associated with highly substituted hydroxyethyl starch N Engl J Med 345 622 623 1:STN:280:DC%2BD3Mvos1yiug%3D%3D 11529231
111. ®, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5 Anesth Analg 92 855 862 1:CAS:528:DC%2BD3MXislyltb0%3D 11273914
112. KA Joorgensen E Stoffersen 1979 Heparin-like activity of albumin Thromb Res 16 69 74
113. T Niemi A Kuitunen 2005 Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis Acta Anaesthesiol Scand 49 373 378 1:CAS:528:DC%2BD2MXjtFansro%3D 15752404
114. TT Niemi RT Suojaranta-Ylinen SI Kukkonen AH Kuitunen 2006 Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery Anesth Analg 102 998 1006 1:CAS:528:DC%2BD28XislWktrg%3D 16551888
115. N Tabuchi J de Haan RC Gallandat Huet PW Boonstra W van Oeveren 1995 Gelatin use impairs platelet adhesion during cardiac surgery Thromb Haemost 74 1447 1451 1:CAS:528:DyaK28Xjtlyhtg%3D%3D 8772218
116. E de Jonge M Levi F Berends AE van der Ende JW ten Cate CP Stoutenbeek 1998 Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects Thromb Haemost 79 286 290 9493577
117. P Innerhofer D Fries J Margreiter A Klingler G Kuhbacher B Wachter E Oswald E Salner B Frischhut W Schobersberger 2002 The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation Anesth Analg 95 858 865 12351257
118. R Beyer U Harmening O Rittmeyer S Zielmann F Mielck S Kazmaier D Kettler 1997 Use of modified fluid gelatin and hydroxyethyl starch for colloidal volume replacement in major orthopaedic surgery Br J Anaesth 78 44 50 1:CAS:528:DyaK2sXhsVeksbs%3D 9059203
119. I Huttner J Boldt G Haisch S Suttner B Kumle H Schulz 2000 Influence of different colloids on molecular markers of haemostasis and platelet function in patients undergoing major abdominal surgery Br J Anaesth 85 417 423 1:CAS:528:DC%2BD3cXmvFKnuro%3D 11103184
120. E de Jonge M Levi 2001 Effects of different plasma substitutes on blood coagulation: a comparative review Crit Care Med 29 1261 1267 11395618
121. JE Knutson JA Deering FW Hall GA Nuttall DR Schroeder RD White CJ Mullany 2000 Does intraoperative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery? Anesth Analg 90 801 807 1:CAS:528:DC%2BD3cXis1yisLo%3D 10735779
122. MM Wilkes RJ Navickis WJ Sibbald 2001 Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding Ann Thorac Surg 72 527 533 1:STN:280:DC%2BD3MvntFarsw%3D%3D 11515893
123. ®) on measures of coagulation Br J Anaesth 89 722 728 1:CAS:528:DC%2BD38XptFOrsrs%3D 12393770
124. SA Kozek-Langenecker C Jungheinrich W Sauermann 2008 Van der Linden P. The effects of hydroxyethyl starch 130/0.4 (6%) on blood loss and use of blood products in major surgery: a pooled analysis of randomized clinical trials Anesth Analg 107 382 390 1:CAS:528:DC%2BD1cXoslGktro%3D 18633012
125. J Boldt T Schölhorn J Mayer S Piper S Suttner 2006 The value of an albumin-based intravascular volume replacement strategy in elderly patients undergoing major abdominal surgery Anesth Analg 103 191 199 16790652
126. B Brandstrup H Tønnesen R Beier-Holgersen E Hjortsø H Erding K Lindorff-Larsen MS Rasmussen C Lanng L Wallin LH Iversen CS Gramkow M Okholm T Blemmer PE Svendsen HH Rottensten B Thage J Riis IS Jeppesen D Teilum AM Christensen B Graungaard F Pott Danish Study Group on Perioperative Fluid Therapy 2003 Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens: a randomized assessor-blinded multicenter trial Ann Surg 238 641 648 14578723